ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
PeopleAdmin
A research position focusing on studying antibodies developed after virus infection or vaccination. The role involves training in various laboratory techniques including antigen or antibody design, protein chemistry, immunoassay development, and system serology.
Headquarters
Folsom, California, United States
Company Size
201-500 employees
Founded
2000
PeopleAdmin, a PowerSchool company, provides cloud-based talent management software solutions for higher education institutions. Its platform supports human resources, academic affairs, faculty management, and student outcomes through tools such as applicant tracking, performance management, and course evaluations. PeopleAdmin serves colleges and universities seeking to streamline recruiting, hiring, developing, and retaining educators and staff.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for PeopleAdmin.
PeopleAdmin didn’t post a salary, so this is our estimate from similar listings.
90% below the average for this role
Associate Scientist
Oxfordbiotherapeutics
Senior Scientist I
bighatbiosciences
Senior Scientist I (Protein & Antibody Production)
Exelixis
Scientist II, Cell Biology
lifelancer
Scientist -Antibody Technologies – Required Flow Cytometry, Tissue Culture & lab Exp)
MillenniumSoft
Associate Scientist/ Sr. Associate Scientist Antibody and Protein Engineering
Mediar Therapeutics